Company Filing History:
2 out of 854 
1 out of 832,843 Years Active: 1993-1999
Title: Innovator in Biotechnology: The Work of Philippe Riberon
Introduction
Philippe Riberon, based in Nogent sur Marne, France, is a notable inventor in the realm of biotechnology. With three patents to his name, he has significantly contributed to the development of recombinant human Interleukin 2. His work focuses on advancing therapeutic applications that can potentially benefit various medical fields.
Latest Patents
Riberon's latest patents include innovations related to the administration of non-glycosylated, recombinant human Interleukin 2 (R-hIL2). He has developed methods regarding its preparation and use, emphasizing a biologically active and reduced form of this important cytokine. These groundbreaking patents are aimed at enhancing therapeutic methodologies involving immune response modulation.
Career Highlights
Throughout his career, Philippe Riberon has worked with prominent organizations, including Roussel Uclaf, where he played a vital role in research and development. His career has been marked by significant achievements in the study of recombinant proteins and their applications in medicine.
Collaborations
Riberon has collaborated with esteemed colleagues, including Pierre Yves Abecassis and Danielle Lando. These partnerships have allowed for a broader exchange of ideas and expertise, fostering innovation in the field of biotechnology and paving the way for future advancements.
Conclusion
Philippe Riberon's contributions to the field of biotechnology through his innovative patents and collaborative work highlight his status as an influential inventor. His ongoing dedication to refining and leveraging recombinant human Interleukin 2 speaks to his commitment to improving medical therapies and addressing critical health challenges.